Taking people in Franciaország1/2. fázis
PHASE IB/II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF CHEMOIMMUNOTHERAPY PLUS SHORT COURSE OF MEK INHIBITOR IN FIRST LINE OF TREATMENT OF METASTATIC NON SQUAMOUS NON SMALL CELL LUNG ADENOCARCINOMA WITH PDL1 <50%
Key facts
- Where
- Dijon, FranciaországSee the site
- Phase
- 1/2. fázis
Where in Franciaország
- Centr Georges Francois LeclercDijon, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centr Georges Francois Leclerc
- Trial code
- EU 2023-508477-87-00
- Record updated
- 2026. július 1.